These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 19957147

  • 1. Nonalcoholic steatohepatitis, animal models, and biomarkers: what is new?
    Ariz U, Mato JM, Lu SC, Martínez Chantar ML.
    Methods Mol Biol; 2010; 593():109-36. PubMed ID: 19957147
    [Abstract] [Full Text] [Related]

  • 2. Non-alcoholic steatohepatitis in children.
    Nanda K.
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [Abstract] [Full Text] [Related]

  • 3. Pathology of nonalcoholic fatty liver disease.
    Yeh MM, Brunt EM.
    Am J Clin Pathol; 2007 Nov; 128(5):837-47. PubMed ID: 17951208
    [Abstract] [Full Text] [Related]

  • 4. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC.
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [Abstract] [Full Text] [Related]

  • 5. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
    Tiniakos DG.
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):643-50. PubMed ID: 19478676
    [Abstract] [Full Text] [Related]

  • 6. Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease.
    Palekar NA, Naus R, Larson SP, Ward J, Harrison SA.
    Liver Int; 2006 Mar; 26(2):151-6. PubMed ID: 16448452
    [Abstract] [Full Text] [Related]

  • 7. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T, Takamura T, Kurita S, Matsuzawa N, Kita Y, Uno M, Akahori H, Misu H, Sakurai M, Zen Y, Nakanuma Y, Kaneko S.
    Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
    [Abstract] [Full Text] [Related]

  • 8. Nonalcoholic fatty liver disease.
    Yu AS, Keeffe EB.
    Rev Gastroenterol Disord; 2002 Jan; 2(1):11-9. PubMed ID: 12122975
    [Abstract] [Full Text] [Related]

  • 9. [Steatosis and steatohepatitis in diabetic patient].
    Hůlek P, Dresslerová I.
    Vnitr Lek; 2011 Apr; 57(4):364-7. PubMed ID: 21612059
    [Abstract] [Full Text] [Related]

  • 10. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH.
    Yoshioka Y, Hashimoto E, Yatsuji S, Kaneda H, Taniai M, Tokushige K, Shiratori K.
    J Gastroenterol; 2004 Dec; 39(12):1215-8. PubMed ID: 15622489
    [Abstract] [Full Text] [Related]

  • 11. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
    Cong WN, Tao RY, Tian JY, Liu GT, Ye F.
    Life Sci; 2008 May 07; 82(19-20):983-90. PubMed ID: 18417155
    [Abstract] [Full Text] [Related]

  • 12. Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model.
    Shindo N, Fujisawa T, Sugimoto K, Nojima K, Oze-Fukai A, Yoshikawa Y, Wang X, Yasuda O, Ikegami H, Rakugi H.
    J Hepatol; 2010 Jun 07; 52(6):903-12. PubMed ID: 20392512
    [Abstract] [Full Text] [Related]

  • 13. The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.
    Wanless IR, Shiota K.
    Semin Liver Dis; 2004 Feb 07; 24(1):99-106. PubMed ID: 15085490
    [Abstract] [Full Text] [Related]

  • 14. Animal models of non-alcoholic steatohepatitis: of mice and man.
    Schattenberg JM, Galle PR.
    Dig Dis; 2010 Feb 07; 28(1):247-54. PubMed ID: 20460919
    [Abstract] [Full Text] [Related]

  • 15. Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model.
    Kamada Y, Matsumoto H, Tamura S, Fukushima J, Kiso S, Fukui K, Igura T, Maeda N, Kihara S, Funahashi T, Matsuzawa Y, Shimomura I, Hayashi N.
    J Hepatol; 2007 Oct 07; 47(4):556-64. PubMed ID: 17459514
    [Abstract] [Full Text] [Related]

  • 16. [Nonalcoholic steatohepatitis--a "new" hepatic disease].
    Grønbaek H, Eivindson MV, Hamilton-Dutoit S, Vilstrup H.
    Ugeskr Laeger; 2003 Mar 10; 165(11):1115-8. PubMed ID: 12677985
    [Abstract] [Full Text] [Related]

  • 17. Pathogenesis of nonalcoholic steatohepatitis (NASH).
    Ma X, Li Z.
    Chin J Dig Dis; 2006 Mar 10; 7(1):7-11. PubMed ID: 16412031
    [Abstract] [Full Text] [Related]

  • 18. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
    Park SH.
    Korean J Hepatol; 2008 Mar 10; 14(1):12-27. PubMed ID: 18367854
    [Abstract] [Full Text] [Related]

  • 19. The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.
    Miele L, Forgione A, Hernandez AP, Gabrieli ML, Vero V, Di Rocco P, Greco AV, Gasbarrini G, Gasbarrini A, Grieco A.
    Eur Rev Med Pharmacol Sci; 2005 Mar 10; 9(5):273-7. PubMed ID: 16231589
    [Abstract] [Full Text] [Related]

  • 20. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future.
    Wieckowska A, McCullough AJ, Feldstein AE.
    Hepatology; 2007 Aug 10; 46(2):582-9. PubMed ID: 17661414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.